연구성과로 돌아가기

2021 연구자 정보 (1033 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Ri, Hyun-Su
(Ri, HS) ⓘ 		Kyungpook Natl Univ, Sch Med, Dept Anesthesia & Pain Med, Daegu 41944, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 78.8] Acute lower extremity arterial thrombosis after intraocular foreign body removal under general anesthesia: A case report and review of literature ⓘ SCIE ⓘ 78.8 MEDICINE, GENERAL & INTERNAL ⓘ ccarrot@pusan.ac.kr; ⓘ
Birwal, A.
(Birwal, A) ⓘ 		제1저자 Univ Delhi, Dept Elect Sci, South Campus, New Delhi 110022, India ⓘ
ⓘ
ⓘ 		[JCR상위 78.9] MIMO/Diversity Antenna with Neutralization Line for WLAN Applications ⓘ SCIE ⓘ 78.9 INSTRUMENTS & INSTRUMENTATION;PHYSICS, APPLIED ⓘ gupta.sachin0708@gmail.com; ⓘ
Kanaujia, B. K.
(Kanaujia, BK) ⓘ 		Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India ⓘ L-6484-2019
kanaujia, Binod ⓘ 		0000-0003-1272-1561
kanaujia, Binod ⓘ 		[JCR상위 78.9] MIMO/Diversity Antenna with Neutralization Line for WLAN Applications ⓘ SCIE ⓘ 78.9 INSTRUMENTS & INSTRUMENTATION;PHYSICS, APPLIED ⓘ gupta.sachin0708@gmail.com; ⓘ
Kumar, S.
(Kumar, S) ⓘ 		교신저자 Kyungpook Natl Univ, Sch Elect Engn, Daegu 41566, South Korea ⓘ W-2211-2019
Kumar, Sachin ⓘ 		0000-0002-6260-6353
Kumar, Sachin ⓘ 		[JCR상위 78.9] MIMO/Diversity Antenna with Neutralization Line for WLAN Applications ⓘ SCIE ⓘ 78.9 INSTRUMENTS & INSTRUMENTATION;PHYSICS, APPLIED ⓘ gupta.sachin0708@gmail.com; ⓘ
Singh, S.
(Singh, S) ⓘ 		Univ Delhi, Inst Informat & Commun, South Campus, New Delhi 110022, India ⓘ G-5396-2012
Singh, Siddhartha ⓘ
ⓘ 		[JCR상위 78.9] MIMO/Diversity Antenna with Neutralization Line for WLAN Applications ⓘ SCIE ⓘ 78.9 INSTRUMENTS & INSTRUMENTATION;PHYSICS, APPLIED ⓘ gupta.sachin0708@gmail.com; ⓘ
Eom, Jung Seop
(Eom, JS) ⓘ 		Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea
Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 79.0] Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer A Multicenter, Retrospective Study ⓘ SCIE ⓘ 79.0 ONCOLOGY ⓘ jiyeonroh@nate.com;ejspulm@gmail.com;leemk@pusan.ac.kr;libertier@gmail.com;jangtw22@hanmail.net;drysh79@gmail.com;son30243@hanmail.net;goodoc@gmail.com;khkmd1205@hanmail.net;shinyup@knu.ac.kr;shin1014@ynu.ac.kr;mihyunkim@pusan.ac.kr; ⓘ
Jang, Taewon
(Jang, T) ⓘ 		Kosin Univ, Gospel Hosp, Dept Pulmonol, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 79.0] Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer A Multicenter, Retrospective Study ⓘ SCIE ⓘ 79.0 ONCOLOGY ⓘ jiyeonroh@nate.com;ejspulm@gmail.com;leemk@pusan.ac.kr;libertier@gmail.com;jangtw22@hanmail.net;drysh79@gmail.com;son30243@hanmail.net;goodoc@gmail.com;khkmd1205@hanmail.net;shinyup@knu.ac.kr;shin1014@ynu.ac.kr;mihyunkim@pusan.ac.kr; ⓘ
Kim, Hyun-Kuk
(Kim, HK) ⓘ 		Inje Univ, Haeundae Paik Hosp, Busan, South Korea ⓘ ISS-7678-2023
Kim, Young-Il ⓘ
ⓘ 		[JCR상위 79.0] Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer A Multicenter, Retrospective Study ⓘ SCIE ⓘ 79.0 ONCOLOGY ⓘ jiyeonroh@nate.com;ejspulm@gmail.com;leemk@pusan.ac.kr;libertier@gmail.com;jangtw22@hanmail.net;drysh79@gmail.com;son30243@hanmail.net;goodoc@gmail.com;khkmd1205@hanmail.net;shinyup@knu.ac.kr;shin1014@ynu.ac.kr;mihyunkim@pusan.ac.kr; ⓘ
Kim, Jehun
(Kim, J) ⓘ 		Kosin Univ, Gospel Hosp, Dept Pulmonol, Busan, South Korea ⓘ A-8216-2019
Kim, Woo ⓘ
ⓘ 		[JCR상위 79.0] Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer A Multicenter, Retrospective Study ⓘ SCIE ⓘ 79.0 ONCOLOGY ⓘ jiyeonroh@nate.com;ejspulm@gmail.com;leemk@pusan.ac.kr;libertier@gmail.com;jangtw22@hanmail.net;drysh79@gmail.com;son30243@hanmail.net;goodoc@gmail.com;khkmd1205@hanmail.net;shinyup@knu.ac.kr;shin1014@ynu.ac.kr;mihyunkim@pusan.ac.kr; ⓘ
Kim, Mi-Hyun
(Kim, MH) ⓘ 		교신저자 Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea
Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea
Pusan Natl Univ, Sch Med, Dept Internal Med, Pusan, South Korea
Pusan Natl Univ Hosp, Biomed Res Inst, Pusan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 79.0] Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer A Multicenter, Retrospective Study
[JCR상위 43.1] Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea ⓘ 		SCIE ⓘ 43.1 ONCOLOGY ⓘ jiyeonroh@nate.com;ejspulm@gmail.com;leemk@pusan.ac.kr;libertier@gmail.com;jangtw22@hanmail.net;drysh79@gmail.com;son30243@hanmail.net;goodoc@gmail.com;khkmd1205@hanmail.net;shinyup@knu.ac.kr;shin1014@ynu.ac.kr;mihyunkim@pusan.ac.kr;
jangtw22@hanmail.net; ⓘ
Lee, Hyun-Kyung
(Lee, HK) ⓘ 		Inje Univ, Busan Paik Hosp, Busan, South Korea
Hanyang Univ, Dept Marine Sci & Convergent Technol, Ansan 15588, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 79.0] Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer A Multicenter, Retrospective Study
[JCR상위 3.1] Nonmonotonic response of type 2 diabetes by low concentration organochlorine pesticide mixture: Findings from multi-omics in zebrafish ⓘ 		SCIE ⓘ 3.1 ONCOLOGY
ENGINEERING, ENVIRONMENTAL;ENVIRONMENTAL SCIENCES ⓘ 		jiyeonroh@nate.com;ejspulm@gmail.com;leemk@pusan.ac.kr;libertier@gmail.com;jangtw22@hanmail.net;drysh79@gmail.com;son30243@hanmail.net;goodoc@gmail.com;khkmd1205@hanmail.net;shinyup@knu.ac.kr;shin1014@ynu.ac.kr;mihyunkim@pusan.ac.kr;
ktkim@seoultech.ac.kr; ⓘ
Lee, Min Ki
(Lee, MK) ⓘ 		Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea
Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 79.0] Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer A Multicenter, Retrospective Study
[JCR상위 23.5] Sequential afatinib and osimertinib in patients with EGFR mutation-positive NSCLC and acquired T790M: A global non-interventional study (UpSwinG) ⓘ 		SCIE ⓘ 23.5 ONCOLOGY
ONCOLOGY;RESPIRATORY SYSTEM ⓘ 		jiyeonroh@nate.com;ejspulm@gmail.com;leemk@pusan.ac.kr;libertier@gmail.com;jangtw22@hanmail.net;drysh79@gmail.com;son30243@hanmail.net;goodoc@gmail.com;khkmd1205@hanmail.net;shinyup@knu.ac.kr;shin1014@ynu.ac.kr;mihyunkim@pusan.ac.kr;
Sanjay.Popat@rmh.nhs.uk;hyunae.jung@samsung.com;shinyup@knu.ac.kr;hausruck@gmail.com;humanmd04@hanmail.net;Carles.escriu@nhs.net;leemk@pusan.ac.kr;mmigliorino@scamilloforlanini.rm.it;leeyc@chonbuk.ac.kr;nicolas.girard2@curie.fr;hasan.daoud@boehringer-ingelheim.com;angela.maerten@boehringer-ingelheim.com;miusat1118@niigata-cc.jp; ⓘ
Roh, Jiyeon
(Roh, J) ⓘ 		제1저자 Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea
Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 79.0] Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer A Multicenter, Retrospective Study ⓘ SCIE ⓘ 79.0 ONCOLOGY ⓘ jiyeonroh@nate.com;ejspulm@gmail.com;leemk@pusan.ac.kr;libertier@gmail.com;jangtw22@hanmail.net;drysh79@gmail.com;son30243@hanmail.net;goodoc@gmail.com;khkmd1205@hanmail.net;shinyup@knu.ac.kr;shin1014@ynu.ac.kr;mihyunkim@pusan.ac.kr; ⓘ
Shin, Kyeong Choel
(Shin, KC) ⓘ 		Yeungnam Univ Hosp, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 79.0] Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer A Multicenter, Retrospective Study ⓘ SCIE ⓘ 79.0 ONCOLOGY ⓘ jiyeonroh@nate.com;ejspulm@gmail.com;leemk@pusan.ac.kr;libertier@gmail.com;jangtw22@hanmail.net;drysh79@gmail.com;son30243@hanmail.net;goodoc@gmail.com;khkmd1205@hanmail.net;shinyup@knu.ac.kr;shin1014@ynu.ac.kr;mihyunkim@pusan.ac.kr; ⓘ
Son, Choon-Hee
(Son, CH) ⓘ 		Dong A Univ Hosp, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 79.0] Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer A Multicenter, Retrospective Study ⓘ SCIE ⓘ 79.0 ONCOLOGY ⓘ jiyeonroh@nate.com;ejspulm@gmail.com;leemk@pusan.ac.kr;libertier@gmail.com;jangtw22@hanmail.net;drysh79@gmail.com;son30243@hanmail.net;goodoc@gmail.com;khkmd1205@hanmail.net;shinyup@knu.ac.kr;shin1014@ynu.ac.kr;mihyunkim@pusan.ac.kr; ⓘ
페이지 이동: